Literature DB >> 11794359

Characteristics of demand for pharmaceutical products: an examination of four cephalosporins.

S F Ellison1, I Cockburn, Z Griliches, J Hausman.   

Abstract

We model demand for four cephalosporins and compute own- and cross-price elasticities between branded and generic versions of the four drugs. We model demand as a multistage budgeting problem, and we argue that such a model is appropriate to the multistage nature of the purchase of pharmaceutical products, in particular the prescribing and dispensing stages. We find quite high elasticities between generic substitutes and also significant elasticities between some therapeutic substitutes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 11794359

Source DB:  PubMed          Journal:  Rand J Econ        ISSN: 0741-6261


  15 in total

1.  Has the European union achieved a single pharmaceutical market?

Authors:  Aysegul Timur; Gabriel Picone; Jeffrey DeSimone
Journal:  Int J Health Care Finance Econ       Date:  2011-10-09

2.  Generic script share and the price of brand-name drugs: the role of consumer choice.

Authors:  John A Rizzo; Richard Zeckhauser
Journal:  Int J Health Care Finance Econ       Date:  2009-01-08

3.  Pharmaceutical pricing: an empirical study of market competition in Chinese hospitals.

Authors:  Jing Wu; Judy Xu; Gordon Liu; Jiuhong Wu
Journal:  Pharmacoeconomics       Date:  2014-03       Impact factor: 4.981

4.  Generic entry, reformulations and promotion of SSRIs in the US.

Authors:  Haiden A Huskamp; Julie M Donohue; Catherine Koss; Ernst R Berndt; Richard G Frank
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

5.  Parallel imports and a mandatory substitution reform: a kick or a muff for price competition in pharmaceuticals?

Authors:  David Granlund; Miyase Yesim Koksal-Ayhan
Journal:  Eur J Health Econ       Date:  2014-11-18

Review 6.  Changing the cost of care for chronic myeloid leukemia: the availability of generic imatinib in the USA and the EU.

Authors:  Rena M Conti; William V Padula; Richard A Larson
Journal:  Ann Hematol       Date:  2015-03-27       Impact factor: 3.673

7.  Private provision of social insurance: drug-specific price elasticities and cost sharing in Medicare Part D.

Authors:  Liran Einav; Amy Finkelstein; Maria Polyakova
Journal:  Am Econ J Econ Policy       Date:  2018-08

8.  By Ounce or By Calorie: The Differential Effects of Alternative Sugar-Sweetened Beverage Tax Strategies.

Authors:  Chen Zhen; Ian F Brissette; Ryan R Ruff
Journal:  Am J Agric Econ       Date:  2014-07-01       Impact factor: 4.082

9.  Pharmaceutical penetration of new drug and pharmaceutical market structure in Taiwan: hospital-level prescription of thiazolidinediones for diabetes.

Authors:  Yi-Wen Tsai; Yu-Wen Wen; Weng-Foung Huang; Ken N Kuo; Pei-Fen Chen; Hsin-Wei Shih; Yue-Chune Lee
Journal:  Eur J Health Econ       Date:  2009-08-02

10.  The effects of drug market regulation on pharmaceutical prices in Europe: overview and evidence from the market of ACE inhibitors.

Authors:  Fritz von der Schulenburg; Sotiris Vandoros; Panos Kanavos
Journal:  Health Econ Rev       Date:  2011-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.